Portolan Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-38,192
| Closed | -$4.14M | – | 183 |
|
|
2020
Q4 | $4.14M | Sell |
38,192
-6,894
| -15% | -$748K | 0.38% | 98 |
|
|
2020
Q3 | $3.99M | Sell |
45,086
-4,781
| -10% | -$423K | 0.45% | 86 |
|
|
2020
Q2 | $5.32M | Sell |
49,867
-1,390
| -3% | -$148K | 0.61% | 68 |
|
|
2020
Q1 | $3.04M | Buy |
51,257
+18,572
| +57% | +$1.1M | 0.46% | 73 |
|
|
2019
Q4 | $2.26M | Buy |
+32,685
| New | +$2.26M | 0.23% | 84 |
|